Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: This is us

If you’ve stumbled upon this blog thinking you will be reading about the attractive and talented cast of the popular 2016 TV show on NBC, I suspect you will be very disappointed. While there is video for you below, you will not see any rippling muscles and you don’t...

BRM2017: State of the regenerative medicine industry

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His...

Right Turn: Primers on cell therapy regulation

Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and...

Right Turn: Stem cell “gun” for wound healing

It has been said that the pen is mightier than the sword. Where, then, does the gun factor in? I was amazed, last year, when I learned of the “biopen,” a medical device that draws stem cells to repair damaged or worn cartilage and then the cartilage heals itself with...

Five regenerative medicine workshops to attend this summer

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness...